eating while pregnant

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

vendredi 26 mars 2010

Question 13. What is ureaplasma, and how did I get it?

Posted on 06:59 by Unknown
Well I am trying to keep up with my schedule of daily posts but life and work keeps getting in my way. Spring Break starts this week so my ability to post daily bits of wisdom to the 3 regular readers of this blog may be limited. My apologies in advance.

Screening for ureaplasma is like religion....some people have religion and some do not! Many REs simply treat all patients and some treat none.... However, one issue is absolutely true and that is the presence of ureaplasma does not suggest marital infidelity. On the other hand, if your spouse likes to hang out with Tiger Woods then all bets are off...

13. What is ureaplasma, and how did I get it?


Most reproductive endocrinologists routinely obtain samples from the cervix (cervical cultures) to assess their patients for gonorrhea, chlamydia, ureaplasma, mycoplasma, and other bacterial infections. Gonorrhea and chlamydia are sexually transmitted diseases that can cause tubal damage and infertility when these bacteria travel from the cervix through the uterus and out into the fallopian tubes. Sexually transmitted infections can be passed back and forth between sexually intimate partners. Patients with gonorrhea may have a yellowish discharge associated with pelvic pain and fever. Although chlamydia can be associated with these symptoms, chlamydial infections are often silent; despite their lack of symptoms, Chlamydia infections may result in significant tubal scarring and damage.

Ureaplasma and mycoplasma are bacteria that can be commonly found in the reproductive tract of both men and women. It is somewhat more problematic to label these two bacteria as reproductive tract pathogens, because they are often found in fertile, healthy couples in addition to those with infertility. Although the presence of these two bacteria have been hypothesized to play a role in both infertility and miscarriage, the specific mechanisms by which they impair fertility remains unclear. The question of whether ureaplasma or mycoplasma can cause reproductive tract damage or whether their presence increases the rate of miscarriage has not been definitively answered. As a consequence, many clinics do not test for ureaplasma or mycoplasma routinely.

If cervical cultures for ureaplasma and mycoplasma are positive, both the patient and her sexual partner are usually treated with antibiotics such as doxycycline. As these bacteria may have been present for many years without causing any symptoms, the finding of ureaplasma and mycoplasma on cervical cultures does not in any way indicate infidelity or sexual misconduct.
Read More
Posted in | No comments

mercredi 24 mars 2010

Question 12: What is a hysteroscopy, and do I need one? Is it the same as a water sonogram or a hysterosalpingogram?

Posted on 07:53 by Unknown
Sometimes you have to learn a new language when dealing with medical issues. Fertility treatment is no exception. Unfortunately, some of our terms sound very similar....especially those that start with HYST. So we have hysteroscopy, hysterosalpingogram, hysterosonogram and hysterectomy. The last one refers to the surgery performed to actually remove the uterus. Clearly, hysterectomy is not a fertility preserving procedure! So when filling out your new patient information, make sure that you only check off hysterectomy if you have indeed undergone a surgery that removed your uterus!

So here is today's Question of the Day! Sorry I missed posting yesterday but it was a kleenex box type of day and I was too wiped out to post.

12. What is a hysteroscopy, and do I need one? Is it the same as a water sonogram or a hysterosalpingogram?

A hysteroscopy is a simple surgical procedure that is performed either to diagnose or to treat a problem within the uterine cavity. During hysteroscopy, the physician inserts a small fiber-optic telescope through the cervix and into the uterus. Either gas or liquid can be used to distend the uterus and allow the physician to directly visualize the uterine cavity. The physician may also introduce small instruments into the uterus to cut scar tissue or remove polyps or fibroids. Although diagnostic hysteroscopy can be performed in the physician’s office under local anesthesia, operative hysteroscopy usually requires anesthesia because of the cramping that occurs during uterine manipulation. Complications of hysteroscopy are rare but may include infection, bleeding, uterine perforation, damage to adjacent structures, and even death.

A water sonogram (hysterosonogram ) is a specialized ultrasound examination performed using a transvaginal ultrasound probe. First, a small catheter is passed through the cervix and into the uterine cavity. Sterile saline is then introduced into the cavity while a transvaginal sonogram is performed allowing the physician to visualize any uterine polyps or fibroids. Usually, a hysterosonogram does not provide any information about the status of the fallopian tubes. Nevertheless, hysterosonograms are helpful in identifying the presence of an endometrial polyp seen on routine sonogram or the location of a fibroid (see Figure 3). A hysterosonogram has limited benefit in evaluating for the presence of uterine scar tissue and is a diagnostic and not therapeutic procedure.

A hysterosalpingogram (HSG) is similar to a hysterosonogram in that fluid is introduced into the uterine cavity. However, the fluid is not saline but rather is a radio-opaque dye. This dye is introduced into the uterus and under fluoroscopy the dye is observed as it sequentially fills the uterine cavity and then passes out into the fallopian tubes and ultimately spills out of the ends of the tubes and into the pelvis . The HSG can be used to diagnose polyps and fibroids and is superior to hysterosonogram in evaluating the presence of uterine scar tissue. This imaging procedure also provides information on the status of the fallopian tubes, unlike either a hysteroscopy or a hysterosonogram. Because it employs traditional x-rays, an HSG is usually performed at a hospital’s radiology department or at a radiologist’s office, since few REs have this equipment in their offices.
Read More
Posted in | No comments

lundi 22 mars 2010

Question 11. What is a laparoscopy, and do I need one?

Posted on 11:47 by Unknown
When I was a medical student at Duke back in the 1980s I spent a rotation with the fertility division that was headed up by Dr. Arthur Haney. Dr. Charles Hammond was the Chairman of the Department and was also an attending in that division. Every Thursday they would have 8-12 laparoscopic surgeries scheduled. A large percentage of these laparoscopies revealed either no problems or very minimal endometriosis. Over the past 20 years the surgical approach to infertility has been replaced by a more rapid move to IVF. However, some patients still benefit from laparoscopy which leads to today's Question of the Day:

11. What is a laparoscopy, and do I need one?

A laparoscopy is an outpatient surgery usually performed under general anesthesia. Most laparoscopies are completed in a hospital, but some physicians utilize freestanding outpatient surgery centers.

During a laparoscopy, the physician inserts a small fiber-optic telescope into the abdominal cavity through an incision made in the patient’s umbilical area (belly button). Most physicians initially distend the abdomen using carbon dioxide gas with a needle (Veres needle) to create what is called a pneumoperitoneum. A trocar—an instrument with a diameter similar to that of a pencil—is then passed through the umbilicus, allowing for introduction of the telescope (called a laparoscope) into the abdomen.

Using the laparoscope, a gynecologic surgeon can inspect the uterus, fallopian tubes, and ovaries. The appendix and upper abdomen are carefully inspected as well. Additional instruments may be inserted into the abdomen through incisions (ports) made along the hairline above the pubic bone. For example, the physician may use graspers, scissors, or suction irrigators to rinse the tissue and remove blood and fluids as needed. Some physicians insert a slightly larger telescope through the umbilical port, which allows them to use a carbon dioxide laser to cut scar tissue or destroy implants of endometriosis. Besides the laser, other instruments can be used to cut or burn abnormalities such as endometriosis or scar tissue.

During a laparoscopy, the physician typically introduces a blue dye into the uterine cavity while directly visualizing the fallopian tubes. If the fallopian tubes are patent (open) but are located in an abnormal location because of scar tissue, then the surgeon may try to free the fallopian tubes to improve the patient’s fertility.

If abnormal ovarian cysts such as endometriomas are present, then the physician may remove them during the course of the laparoscopy or, if necessary, perform a laparotomy. A laparotomy is a surgery performed through a larger incision, usually made along the bikini line. It may require the patient to stay 1 to 3 days in the hospital following the surgery. In addition, a laparotomy requires a longer recovery period and may create more new scar tissue than laparoscopic surgery.

Certain abnormalities cannot be easily treated through laparoscopy, including exceedingly large ovarian cysts, ovarian cysts that are suspicious for cancer, and fibroids that are deeply embedded in the wall of the uterus. Patients with these problems are probably better served by a laparotomy.

For many years, all women who were seeking fertility care underwent laparoscopy as part of the initial evaluation. In recent times, this practice has faded with increased utilization of IVF. Although IVF has essentially replaced tubal surgery in patients with tubal factor infertility, laparoscopy is still used to correct certain problems in patients prior to undergoing IVF. For patients uninterested in IVF (for religious, financial or philosophical reasons), laparoscopy may still represent an important part of their diagnostic and therapeutic options. Complications of laparoscopy are rare but can include injury to the bowel, bladder, and blood vessels; a need for laparotomy; and even death.
Read More
Posted in | No comments

vendredi 19 mars 2010

Question 10. What is antimullerian hormone and what does this test tell my doctor?

Posted on 10:29 by Unknown
TGIF. Yup, it is Friday afternoon here at Dominion and I am looking forward to a free weekend. For the past 10 years it has been just myself and Dr. DiMattina and I can tell you that every other weekend on call can wear you down....especially if the other guy has vacation. Before I joined him, Dr. DiMattina never took a vacation and at one point had to remove his own appendix with a spoon immediately following an egg collection which was performed at 2 am since this was in the days before Lupron...or ultrasound...or anesthesia....or electricity (if you catch my drift). Still as long as you give the staff bagels and muffins the weekends run quite smoothly.

So what about newer tests of ovarian reserve? The use of AMH is kinda like religion..either you are a believer or you are not. We are believers in AMH here at Dominion. I find it to be very helpful in assessing patients for IVF protocols and for making a host of other treatment related decisions. However, I would not ask your Ob Gyn to check this hormone as the interpretation of the results can be tricky.

Hope all of you have a great weekend and here is the Question of the Day!


10. What is antimullerian hormone and what does this test tell my doctor?

AMH is a protein hormone produced by the cells that directly surround the egg, called the granulosa cells. Granulosa cells (GC) also produce the hormones estrogen and progesterone. Since the cells that surround each egg produce AMH, we can measure a patient’s blood AMH level and get a good determination of her total follicle pool or total egg count. If her AMH level is low, then her total follicle pool or egg count is also probably low. AMH offers additional insight into the patient’s ovarian reserve in addition to the other tests such as serum day 3 FSH, day 3 estradiol, clomiphene citrate challenge testing (CCCT), or an ovarian ìantralî follicle count (AFC) using ultrasonography. Since cycle day 3 FSH levels often fluctuate widely, a single measure of FSH may not represent a patient’s true ovarian reserve especially if AMH and antral follicle count are normal.

The advantage of serum AMH testing is that AMH can be measured on any day of the patient’s menstrual cycle. In other words, its levels are cycle day independent, so patients don’t have to worry whether or not the blood sample is collected on day 3. Also, its levels tend to be more constant and more reliable for assessing ovarian reserve than day 3 serum FSH and estradiol. We often observe patients whose day 3 FSH and estradiol levels are normal indicating normal ovarian reserve, yet their AMH level is low and consistent with an observed low antral follicle count suggesting diminished ovarian reserve. Upon performing ovarian stimulation on such patients using gonadotropins, we often find that the AMH and antral follicle count properly identified the patient’s true ovarian reserve better than using serum day 3 FSH and estradiol measurements.

At Dominion Fertility, we place much more emphasis on AMH levels than we do on the other blood markers for ovarian reserve. In Europe, AMH is also the preferred biomarker for assessing ovarian reserve in many IVF centers but the use of AMH in the United States is becoming increasingly more popular.
Read More
Posted in | No comments

jeudi 18 mars 2010

Question 9. What is ovarian reserve, and how is it tested?

Posted on 06:34 by Unknown
Ovarian reserve is a very important but confusing topic. I would like to share an interesting story about ovarian reserve before getting to the Question of the Day on this day after Saint Patrick's Day. For those reading this blog on Fertile Grounds, feel free to skip to the Question if you have already read this story in my post.

DK is a 38 year old who came to see me in September 2008. She and her husband had undergone fertility treatment 3 years earlier at another center and conceived with CC/FSH/IUI but had a quintuplet pregnancy that ultimately ended up as twins. They were very worried about having another multiple pregnancy and wished to discuss options.

However, as part of the evaluation her FSH was found to be 14 with a normal E2 but an AMH of<0.1 and an antral follicle count of 2-3. Although they had originally considered stimulated IVF with single embryo transfer that option seemed unlikely given her diminished ovarian reserve. After failing a few natural cycle IUIs they decided to try Natural Cycle IVF in 2009. Their first Natural Cycle IVF was a biochemical pregnancy. They tried Natural Cycle IVF again in June 2009 and were successful. She was sent off to her Ob Gyn with a normal looking pregnancy.

But the roller coaster was just getting cranked up....

She underwent a CVS given her age and the results showed that some of the cells were normal but some were trisomy 9 (not compatible with life). Her Ob Gyn was suggesting a D&C so she called me just to let me know what was going on. I fired off an email to Dr Mark Hughes (the world's smartest geneticist). Since we know that the 8 cell human embryo can contain both normal and abnormal cells (limiting the usefulness of PGS) I was thinking that maybe the CVS results represented a case of placental mosaicism where the baby is normal but the placenta has both normal and abnormal cells. Dr. Hughes confirmed that was indeed possible.

The couple elected to continue the pregnancy and undergo amniocentesis. The amnio was totally normal and all sonograms were normal. She went full term and just went home from the hospital today after delivering a healthy 9 pound baby!

So this case demonstrates many interesting points. First of all, is Natural Cycle IVF appropriate in a couple with normal tubes, normal sperm and previous pregnancy? The answer was a resounding "yes" in this case. Secondly, can ovarian reserve drop dramatically in just a few years? The answer is "yes" and although this case is a bit unusual in that the patient went from quints to diminished ovarian reserve in just 3 years. Thirdly, this case does demonstrate again the limitations of PGD/PGS and even CVS in cases of mosaicism. Finally, this case shows how important it is to consider all options especially when confronted with an unexpected result (like mosaicism on CVS).

I am so happy for this family and considering that I am not a big lover of roller coasters, all I can say is a few more wild rides like that one and I probably wont have any hair left at all!

9. What is ovarian reserve, and how is it tested?


During a woman’s reproductive cycle, each month a single follicle is selected out of a group of potential follicles, reaches maturity, and ovulates a single egg. Many fertility treatments use medications to “rescue” other follicles from that group, so that multiple eggs are released during ovulation as opposed to just a single egg. If physicians could predict which patients would respond well to fertility treatments, then those women predicted to produce a low number of eggs with a poor chance of success with stimulated cycle IVF could defer this treatment and consider other options including unstimulated or Natural Cycle IVF. Those women who respond well to fertility medications are described as having normal ovarian reserve. Those patients who have a poor response to fertility medications are described as having diminished ovarian reserve. Although those patients with diminished ovarian reserve are likely to demonstrate suboptimal numbers of eggs during a stimulated IVF cycle, they may still conceive spontaneously, or with non-IVF treatments or with Natural cycle IVF.

Ovarian reserve consists of two separate components, both of which determine a woman’s chance of conceiving a child with IVF. The first component is the number of extra follicles that are available to undergo recruitment with treatment using fertility medications. This number depends on several factors, including the woman’s chronological age (as discussed below), previous ovarian surgery, genetics, and exposure to environmental toxins (most notably, tobacco usage).

The second component is the actual health of the follicles and the eggs within those follicles. First and foremost, egg quality is determined by a woman’s chronological age. Peak female fertility occurs when a woman is in her twenties and then drops significantly with age, especially following age 35. This fact has been conclusively demonstrated in many ways but is especially obvious when we look at IVF pregnancy rates. In patients who undergo IVF, studies have shown that around the age of 35 years old a marked decrease occurs in the chance of an embryo implanting successfully. In addition, the miscarriage rate rises with age, especially in those women older than age 40, in whom this rate exceeds 50%. Therefore, the age component of ovarian reserve is essentially immutable. In other words, unless she uses eggs from an egg donor, a woman cannot change her chronological age—and with increasing age, the number of normal eggs inevitably falls sharply. Although it is true that the percentage of normal eggs within an ovary is specific to the individual woman, even the most fertile women possess very few normal eggs after age 40.

The concept of ovarian reserve testing, therefore, represents a means by which the physician attempts to evaluate a woman’s reproductive potential both in terms of the number of follicles that remain and the health of those follicles. There are several ways in which one can assess ovarian reserve. First, the woman’s follicle-stimulating hormone (FSH) level can be measured on day 2 or 3 of a normal menstrual cycle. An estradiol level should be obtained at the same time, because the FSH level can be misleadingly low in women who have a high estrogen level early in the menstrual cycle. Alternatively, ovarian reserve can be assessed by performing a transvaginal ultrasound and counting the antral follicles present. In women with a slightly elevated FSH level, a transvaginal ultrasound may reveal a large number of follicles—somewhat reassuring the patient and her physician that perhaps her ovarian reserve is more normal than might otherwise be expected.

Unfortunately, normal FSH and estradiol levels do not guarantee a normal response to fertility medications. The clomiphene citrate challenge test (CCCT) was initially described as a means to identify those women with normal FSH and estradiol levels on day 3 of the menstrual cycle (day-3 hormones) who may demonstrate a suboptimal response to injectable fertility medications and poor IVF pregnancy rates. In the CCCT, the patient takes 100 mg of clomiphene citrate on cycle days 5 through 9. An FSH level is checked on days 3 and 10. If both of these levels are less than 10 IU/L (international units), then this represents a normal response. If the FSH level is greater than 10 IU on day 3 but less than 10 IU on day 10, then this represents a borderline situation, but potentially reassuring based on the response of the ovary to stimulation with clomiphene citrate. If the FSH level is normal on day 3 but more than 10 IU on day 10, however, the woman is likely to exhibit a suboptimal response to fertility medication, along with high IVF cancellation rates and poor pregnancy rates.

Antimullerian hormone (AMH) is another blood hormone test that is often used to assess ovarian reserve. Many experts believe that AHM is a better indicator of ovarian reserve than serum FSH as it has less cycle to cycle variability. See Question XX for more information on AMH.

A word of caution is in order regarding ovarian reserve testing, including the CCCT: Virtually all physicians have patients who have successfully delivered a child following an abnormal CCCT. An abnormal CCCT or elevated FSH levels on cycle day 3 do not preclude spontaneous pregnancy and delivery. Nevertheless, the miscarriage rate and the incidence of Down syndrome may be increased in such pregnancies. Patients with diminished ovarian reserve may have successful treatment with the combination of fertility drugs and intra-uterine insemination (IUI), or even with IUI alone. More recently, unstimulated or Natural Cycle IVF has gained increased popularity in treating patients with diminished ovarian reserve. A recent paper from Italy described 500 Natural Cycle IVF cycles in patients who had previously failed to respond to ovarian stimulation medications. In spite of having such a poor history, over 10% of the women under 40 years of age achieved a pregnancy. Considering that in the United States, most of these women would have only been offered donor egg IVF, we consider that pregnancy rate to be very remarkable.

The real benefit of the CCCT is its ability to identify often those patients in whom stimulated IVF is markedly less likely to be successful, allowing them to focus on other options such as unstimulated IVF, donor-egg IVF, adoption, or less invasive office-based fertility treatments. Overall, ovarian reserve testing represents an important factor when considering various fertility treatments and may be the final arbitrator in selecting the specific treatment plan.

Rebecca comments:

I first walked into my RE's office at the age of 39. I had just suffered the loss of a pregnancy that had taken me 8 months to conceive. I was very aware of the proverbial 'biological time clock' and was concerned that my husband and I may have run out of time. I was panic stricken about the tests that would evaluate my ovarian reserve, however my desire to have children was greater than the fear I had about the test results. Fortunately, we found an RE who did not rely solely on my chronological age when he discussed our treatment options with us. He reviewed all my medical tests with me and offered an individualized plan that included a number of family building options that might address my infertility issues (most likely age related). Looking back, I realize how important our choice of RE was. It is important for women of advanced maternal age (AMA) to quickly identify an RE that is willing to work with, and is experienced in working with, women of AMA. An AMA woman must find a fertility clinic that offers a variety of fertility treatment options; one size (or one treatment) does NOT fit all. And finally, an AMA woman must find an RE who is willing to be aggressive in her treatment, but is also capable of being honest about the limitations of those treatment options for an AMA woman.
Read More
Posted in | No comments

mercredi 17 mars 2010

Question 8: What tests will we have to undergo as part of a fertility evaluation?

Posted on 05:57 by Unknown
Happy Saint Patrick's Day from Dr. G and the rest of the staff here at Dominion Fertility. Let me tell you that Dr. DiMattina's outfit today puts mine to shame! If only all of you could see his day-glo green shoes, belt, tie and hat. Oh well. Perhaps I will post some photos of him this week so you can see what you missed by not hanging out at Dominion Fertility.

Most patients are anxious about coming to see the fertility specialist because they just don't know what to expect in terms of testing and treatment. In general, most REs approach the testing phase in a similar fashion as detailed below. The women are usually quite easy to work with while the men are usually pretty resistant. I think that getting reduced down to a number is problematic for many of us. Yes it can be embarrassing to have to do a semen analysis but that's just the way it is!

Happy Saint Patrick's Day!



8. What tests will we have to undergo as part of a fertility evaluation?

The basic infertility evaluation consists of a handful of tests. The woman typically undergoes a transvaginal ultrasound, hormone blood tests, an assessment of the fallopian tubes and uterus (by x-ray or by laparoscopic surgery). The man gets off relatively easily as he usually only undergoes a semen analysis.

Transvaginal ultrasound allows the physician to assess the appearance of the uterus and the ovaries. During this examination, the physician may discover uterine abnormalities such as fibroids (benign growths of the muscle of the uterus) or uterine polyps (benign growths of the lining of the uterus). Ultrasonography can also identify the location of the ovaries and determine the number of follicles present (antral follicle count), which correlates with the woman’s response to fertility medications. In addition, examination of the ovaries may reveal the presence of abnormal ovarian cysts such as endometriomas, dermoid cysts, or—in rare cases—precancerous and cancerous lesions.

In addition to the routine vaginal ultrasound, an assessment of the fallopian tubes and the uterine cavity is appropriate when the woman is having trouble conceiving. This examination is usually accomplished through a hysterosalpingogram (HSG: see Figure 2), an x-ray test that is performed under fluoroscopy by a gynecologist, a reproductive endocrinologist or a radiologist. Although it may sometimes cause mild uterine cramping, the vast majority of patients tolerate this procedure without difficulty. The individual physician performing this test can make a huge difference in the experience for a typical patient. For example, we utilize a soft catheter which is held in place against the cervix but is not actually passed into the uterine cavity. The use of this instrument rather that a balloon type catheter that must be introduced through the cervix and into the uterus can markedly reduce patient discomfort with this test. Similarly, only a small volume of dye is needed to fill the uterus and fallopian tubes. Excessive pressure and volume of dye can lead to much greater cramping and rarely improves the diagnostic accuracy of the test.
Alternatives to the hysterosalpingogram include laparoscopy and hysteroscopy; these outpatient surgical procedures are described in Questions 10 and 11.

Laboratory tests on the female partner of an infertile couple usually include routine screening tests such as those for blood type, blood count, and rubella immunity. In addition, most physicians perform tests that check the woman’s prolactin and thyroid-stimulating hormone (TSH) levels. Additional reproductive hormone testing for ovarian reserve is usually part of the routine evaluation as well (see Question 9).

Routine testing of the male partner of an infertile couple includes a basic semen analysis evaluating the volume of semen, the concentration of sperm (sperm count), the percentage of moving sperm (sperm motility), and the percentage of normally shaped sperm (sperm morphology). (See Table 2.) Although some clinics perform additional sperm function tests, such as the acrosome reaction and hypo-osmotic swelling test, the overall benefit of these two tests remains somewhat controversial. Both of these tests attempt to predict the functional ability of the sperm in terms of its ability to fertilize an egg. Ultimately, however, the best evidence of normal sperm function is a recent pregnancy or normal fertilization during a cycle of IVF.

Tests to detect the presence of antisperm antibodies in the blood of the female partner or coating the individual sperm may sometimes be recommended. Female antisperm antibodies may cause infertility that is best treated by IVF. Antisperm antibodies present on the sperm themselves may inhibit normal fertilization. In such cases, collecting a semen sample in media for use in artificial insemination may be considered, but these patients are usually recommended to pursue IVF with intracytoplasmic sperm injection (ICSI).

Kristin comments:

Despite having a diagnosis of PCOS when I was referred to an RE, I still had to go through the regular battery of blood tests, ultrasounds, and an HSG. It was a really scary time because none of my friends had ever gone through any of the tests and I really felt like a pincushion. Besides the physical toll of the tests, it was definitely emotionally draining. I think the initial tests in some ways prepare you for the weeks of daily blood draws and ultrasounds that accompany IUI [intra-uterine insemination] and IVF. Before IVF I was terrified of needles, but within days I was a pro at giving myself shots.
Read More
Posted in | No comments

mardi 16 mars 2010

Question 7: What are typical causes of infertility?

Posted on 08:09 by Unknown
Being a fertility specialist is a bit like being a detective. You gather the evidence and then work on a hypothesis. Once you have the hypothesis, then you can test it out and see if the problem is resolved. Today I saw a new patient that was very frustrated with her situation and the response that she had gotten from her previous physicians. I listened carefully to her story and then explained carefully what I thought explained her particular problem. We now have a plan to test my hypothesis. If I am right then we will all be very happy, but I think that even if I am wrong then at least the couple understood how I approached the problem in a logical fashion.

Ultimately there are not that many fertility issues and common things are common. But every patient has their own story to tell and we need to listen in order to make sound decisions. So what types of problems do we deal with? Good question and the topic of today's Question of the Day from the upcoming 2nd Edition of 100 Questions and Answers about Infertility.


7. What are typical causes of infertility?

The causes of infertility are wide ranging but can be examined in light of the reproductive cycle described in Question 1. (See Table 1.) In general, the causes of infertility can be equally divided between the male and female partners in a couple.

Half of all infertility cases, therefore, involve problems with the sperm of the male partner. Unfortunately, functional tests for sperm competence (the ability of sperm to fertilize an egg) are not available leaving us to rely upon the descriptive components of the semen analysis. A complete semen analysis should include the total number of sperm (concentration), the percentage of those sperm that are moving (motility), and the shape of those sperm (morphology).

Many factors can reduce the female partner’s ability to conceive. For example, a woman may have anatomical problems related to the fallopian tubes, uterus, and peritoneal structures within the pelvis such as adhesions or endometriosis. Problems with ovulation are very common in infertile patients, and women with irregular periods may suffer from a common disorder such as polycystic ovarian syndrome (PCOS). Another major fertility factor is reproductive aging. Peak fertility occurs when a woman is in her twenties, and it declines significantly during her thirties and forties. The rate of decline increases after the age of 35 as is evident in decreased IVF pregnancy rates and decreased embryo implantation rates in this age group.
Read More
Posted in | No comments
Articles plus récents Articles plus anciens Accueil
Inscription à : Articles (Atom)

Popular Posts

  • Avoid getting stung...advice from Dr G at Dominion Fertility
    No good deed goes unpunished. I spend a fair amount of time traveling between our Fair Oaks and Arlington offices in order to do my best to ...
  • Going to Blast!
    “Going to blast” is different than “having a blast.” When your RE talks about going to blast he/she is referring to the stage of embryo deve...
  • Managing DOR at Dominion Fertility
    Here in Washington DC we love acronyms. The entire government is one big acronym....DHS, HHS, DOJ, IRS, etc, etc. In medicine we are similar...
  • Stim...retrieve...transfer....fail....repeat. NOT the Dominion Fertility approach to IVF.
    Readers of this blog know that I have wide ranging taste in movies. On the one hand I loved Frozen and have been known to sing along with Br...
  • Happy Valentine's Day from Dominion Fertility
    DrG wishing you all an early Happy Valentine's Day just in case I don't make it home in one piece given the "wicked" (Bost...
  • Salon.com got it right. DrG at Dominion Fertility agrees.
    Over a decade ago I received an odd email from the folks at Salon.com. They had seen my book: Obstetrics, Gynecology and Infertility: Handbo...
  • Roller Coasters, Car Keys and the Use of the Matcher System at Dominion Fertility.
    I am really not a roller coaster aficionado. In fact, I sometimes have a tough time with elevators that drop too fast....So when I recently ...
  • Speaking the Truth with Love
    I was not one of the cool kids in high school. Part of this was because I was, more or less, a "goody-two shoes" and gave my paren...
  • You say tow-mah-tow and I say tow-may-tow
    I agree that the medical profession has too many abbreviations and that it is hard to know how to act knowledgeable in front of your RE. So ...
  • Happy (Belated) New Year from Dominion Fertility!
    It has been a very busy couple of months here at Dominion Fertility but I am slowly digging out from a number of time consuming projects ran...

Blog Archive

  • ▼  2014 (10)
    • ▼  juillet (1)
      • Stim...retrieve...transfer....fail....repeat. NOT ...
    • ►  juin (1)
    • ►  mai (1)
    • ►  avril (1)
    • ►  mars (1)
    • ►  février (2)
    • ►  janvier (3)
  • ►  2013 (14)
    • ►  décembre (1)
    • ►  novembre (1)
    • ►  octobre (1)
    • ►  septembre (1)
    • ►  août (1)
    • ►  juillet (1)
    • ►  juin (1)
    • ►  mai (1)
    • ►  avril (1)
    • ►  mars (2)
    • ►  février (1)
    • ►  janvier (2)
  • ►  2012 (30)
    • ►  décembre (2)
    • ►  novembre (1)
    • ►  octobre (3)
    • ►  septembre (1)
    • ►  août (2)
    • ►  juillet (2)
    • ►  juin (3)
    • ►  mai (2)
    • ►  avril (2)
    • ►  mars (3)
    • ►  février (6)
    • ►  janvier (3)
  • ►  2011 (28)
    • ►  décembre (2)
    • ►  novembre (3)
    • ►  octobre (1)
    • ►  septembre (2)
    • ►  juillet (3)
    • ►  juin (2)
    • ►  mai (2)
    • ►  avril (3)
    • ►  mars (5)
    • ►  février (3)
    • ►  janvier (2)
  • ►  2010 (52)
    • ►  décembre (2)
    • ►  novembre (6)
    • ►  octobre (5)
    • ►  septembre (4)
    • ►  août (1)
    • ►  juillet (4)
    • ►  juin (3)
    • ►  mai (4)
    • ►  avril (9)
    • ►  mars (13)
    • ►  janvier (1)
  • ►  2009 (22)
    • ►  novembre (1)
    • ►  octobre (2)
    • ►  septembre (2)
    • ►  août (2)
    • ►  juillet (4)
    • ►  mai (2)
    • ►  avril (1)
    • ►  mars (3)
    • ►  février (2)
    • ►  janvier (3)
  • ►  2008 (27)
    • ►  décembre (2)
    • ►  novembre (1)
    • ►  octobre (3)
    • ►  septembre (6)
    • ►  juillet (1)
    • ►  juin (2)
    • ►  mai (3)
    • ►  avril (2)
    • ►  mars (1)
    • ►  février (2)
    • ►  janvier (4)
  • ►  2007 (66)
    • ►  décembre (1)
    • ►  novembre (5)
    • ►  octobre (6)
    • ►  septembre (7)
    • ►  août (11)
    • ►  juillet (13)
    • ►  juin (22)
    • ►  mai (1)
Fourni par Blogger.

Qui êtes-vous ?

Unknown
Afficher mon profil complet